The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...

Ensem Therapeutics, Inc. (ENSEM), a clinical-stage, oncology-focused biopharmaceutical company, today announced that the first patient has been dosed with ETX-636 in China at Fudan University Shanghai ...

Vitalik Buterin Proposes Fix For Content-Creator Coin Model. Ethereum co-founder Vitalik Buterin has proposed a novel creator ...

Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma ...

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positiv ...